FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012553679> ?p ?o ?g. }

• W2012553679 endingPage "1395" @default.
• W2012553679 startingPage "1388" @default.
• W2012553679 abstract "Inhaled nitric oxide (iNO) causes selective pulmonary vasodilation by increasing pulmonary vascular levels of cyclic guanosine monophosphate (cGMP). Dipyridamole, a drug with several putative vasodilator mechanisms, is an inhibitor of cGMP-specific phosphodiesterases (PDE5); it therefore has the potential to increase pulmonary vascular cGMP levels, lower pulmonary vascular resistance, augment iNO-induced pulmonary vasodilation, and attenuate excessive pulmonary vasoreactivity. To test dipyridamole in the pulmonary circulation, we studied pediatric patients undergoing cardiac catheterization who had severe resting pulmonary hypertension (Group 1; n = 11) or exaggerated acute hypoxia-induced pulmonary vasoconstriction (Group 2; n = 4). In Group 1, we compared the effects of iNO (20 ppm), dipyridamole (0.6 mg/kg), and combined treatments (iNO + dipyridamole) on pulmonary and systemic hemodynamics. In Group 2 we measured the pulmonary and systemic effects of dipyridamole while the patients were breathing room air and hypoxic gas mixtures (FIO2 = 0.16). One patient in Group 1 had a hypotensive response to dipyridamole and was exluded from study. In the remaining 12 studies done on 10 patients, iNO caused a selective decrease in mean pulmonary artery pressure (Ppa) and indexed pulmonary vascular resistance (PVRI) without affecting mean aortic pressure (Pao) or indexed systemic vascular resistance (SVRI). Dipyridamole decreased PVRI to similar values as did iNO, but this effect was primarily due to an increase in cardiac index (CI), and was not associated with any change in Ppa, and was associated with a decrease in Pao and SVRI. In comparison with individual treatments, combined therapy (iNO + dipyridamole) did not augment pulmonary vasodilation in the group as a whole; however, in 50% of patients, combined therapy decreased PVRI by 20% more than did iNO or dipyridamole alone. In Group 2, Ppa and the pulmonary-to-systemic resistance ratio (Rp/Rs) increased to suprasystemic levels during acute hypoxia. Pretreatment with dipyridamole blunted the increase in Ppa and Rp/Rs during repeat hypoxia, keeping Ppa at a subsystemic level and Rp/Rs < 1. We conclude that: (1) dipyridamole nonselectively reduces PVRI, primarily through an increase in CI; (2) in combination with iNO, dipyridamole augments the decrease in PVRI in some patients; and (3) dipyridamole blunts the severity of acute hypoxic pulmonary vasoconstriction in children with exaggerated hypoxic pressor responses." @default.
• W2012553679 created "2016-06-24" @default.
• W2012553679 creator A5023923057 @default.
• W2012553679 creator A5057930855 @default.
• W2012553679 creator A5058064641 @default.
• W2012553679 creator A5064134132 @default.
• W2012553679 creator A5079675484 @default.
• W2012553679 creator A5085660376 @default.
• W2012553679 date "1998-11-01" @default.
• W2012553679 modified "2023-10-18" @default.
• W2012553679 title "Effects of Dipyridamole and Inhaled Nitric Oxide in Pediatric Patients with Pulmonary Hypertension" @default.
• W2012553679 cites W1550626564 @default.
• W2012553679 cites W187224587 @default.
• W2012553679 cites W1927797304 @default.
• W2012553679 cites W1961363060 @default.
• W2012553679 cites W1972724464 @default.
• W2012553679 cites W1975375483 @default.
• W2012553679 cites W1979807068 @default.
• W2012553679 cites W1986606267 @default.
• W2012553679 cites W1986842137 @default.
• W2012553679 cites W1987013989 @default.
• W2012553679 cites W1991571348 @default.
• W2012553679 cites W1992983801 @default.
• W2012553679 cites W1994440138 @default.
• W2012553679 cites W1996810428 @default.
• W2012553679 cites W2000075945 @default.
• W2012553679 cites W2002822787 @default.
• W2012553679 cites W2014508183 @default.
• W2012553679 cites W2015247808 @default.
• W2012553679 cites W2023299923 @default.
• W2012553679 cites W2024649391 @default.
• W2012553679 cites W2026668204 @default.
• W2012553679 cites W2026672837 @default.
• W2012553679 cites W2031480665 @default.
• W2012553679 cites W2034035138 @default.
• W2012553679 cites W2036246796 @default.
• W2012553679 cites W2038418152 @default.
• W2012553679 cites W2042322531 @default.
• W2012553679 cites W2042631424 @default.
• W2012553679 cites W2047423001 @default.
• W2012553679 cites W2055203846 @default.
• W2012553679 cites W2055540070 @default.
• W2012553679 cites W2058599044 @default.
• W2012553679 cites W2062576507 @default.
• W2012553679 cites W2064860012 @default.
• W2012553679 cites W2068600461 @default.
• W2012553679 cites W2070901252 @default.
• W2012553679 cites W2071331983 @default.
• W2012553679 cites W2089925991 @default.
• W2012553679 cites W2091542340 @default.
• W2012553679 cites W2106912602 @default.
• W2012553679 cites W2114355469 @default.
• W2012553679 cites W2124497039 @default.
• W2012553679 cites W2128139551 @default.
• W2012553679 cites W2140036859 @default.
• W2012553679 cites W2159435494 @default.
• W2012553679 cites W2161671586 @default.
• W2012553679 cites W2166403487 @default.
• W2012553679 cites W2313158847 @default.
• W2012553679 cites W4231934396 @default.
• W2012553679 cites W4253039236 @default.
• W2012553679 cites W4295813408 @default.
• W2012553679 doi "https://doi.org/10.1164/ajrccm.158.5.9710117" @default.
• W2012553679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9817684" @default.
• W2012553679 hasPublicationYear "1998" @default.
• W2012553679 type Work @default.
• W2012553679 sameAs 2012553679 @default.
• W2012553679 citedByCount "88" @default.
• W2012553679 countsByYear W20125536792012 @default.
• W2012553679 countsByYear W20125536792013 @default.
• W2012553679 countsByYear W20125536792014 @default.
• W2012553679 countsByYear W20125536792016 @default.
• W2012553679 countsByYear W20125536792017 @default.
• W2012553679 countsByYear W20125536792018 @default.
• W2012553679 countsByYear W20125536792020 @default.
• W2012553679 countsByYear W20125536792021 @default.
• W2012553679 crossrefType "journal-article" @default.
• W2012553679 hasAuthorship W2012553679A5023923057 @default.
• W2012553679 hasAuthorship W2012553679A5057930855 @default.
• W2012553679 hasAuthorship W2012553679A5058064641 @default.
• W2012553679 hasAuthorship W2012553679A5064134132 @default.
• W2012553679 hasAuthorship W2012553679A5079675484 @default.
• W2012553679 hasAuthorship W2012553679A5085660376 @default.
• W2012553679 hasConcept C120770815 @default.
• W2012553679 hasConcept C126322002 @default.
• W2012553679 hasConcept C164705383 @default.
• W2012553679 hasConcept C178853913 @default.
• W2012553679 hasConcept C2776766087 @default.
• W2012553679 hasConcept C2776890861 @default.
• W2012553679 hasConcept C2780930700 @default.
• W2012553679 hasConcept C2780940725 @default.
• W2012553679 hasConcept C2780994212 @default.
• W2012553679 hasConcept C29323129 @default.
• W2012553679 hasConcept C42219234 @default.
• W2012553679 hasConcept C519581460 @default.
• W2012553679 hasConcept C58245268 @default.
• W2012553679 hasConcept C71924100 @default.
• W2012553679 hasConceptScore W2012553679C120770815 @default.

• next